<DOC>
	<DOCNO>NCT01439945</DOCNO>
	<brief_summary>RATIONALE : Magnesium oxide may help relieve hot flash symptom woman history breast cancer . PURPOSE : This randomized clinical trial study well high-dose low-dose magnesium oxide work compare placebo treat menopausal woman hot flash history breast cancer .</brief_summary>
	<brief_title>Magnesium Oxide Treating Postmenopausal Women With Hot Flashes History Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate efficacy magnesium oxide hot flash woman history breast cancer . Secondary - Evaluate side-effect profile magnesium oxide study population . - Evaluate effect magnesium oxide secondary outcome hot flash frequency , hot flash severity , toxicity ( include diarrhea ) , hot flash-related daily interference activity . - Evaluate effect magnesium oxide change magnesium level ( first 150 patient ) . OUTLINE : This multicenter study . Patients stratify accord age ( 18-49 year vs ≥ 50 year ) , current tamoxifen and/or selective estrogen receptor modulator ( yes v ) , current aromatase inhibitor ( yes v ) , daily frequency hot flash ( 4-9 v ≥ 10 ) . Patients randomize 1 4 treatment arm . - Arm I : Patients receive low-dose magnesium oxide orally ( PO ) daily ( QD ) . - Arm II : Patients receive high-dose magnesium oxide PO QD . - Arm III : Patients receive low-dose placebo PO QD . - Arm IV : Patients receive high-dose placebo PO QD . In arm , treatment continue 8 week absence unacceptable toxicity . Some patient may continue crossover receive magnesium 4 week . Patients complete Hot Flash Diary daily 9 week begin 1 week treatment . They also complete Symptom Experience Questionnaire , Profile Mood States ( POMS ) , Hot Flash-Related Daily Interference Scale ( HFRDIS ) questionnaires periodically study treatment . Patients undergo blood sample collection baseline end week 5 9 serum magnesium level analysis .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Women history breast cancer ( currently without malignant disease ) Bothersome hot flash ( define occurrence ≥ 28 time per week sufficient severity make patient desire therapeutic intervention ) Presence hot flash ≥ 30 day prior study registration Willingness provide biologic specimen require protocol Hormone receptor status specify PATIENT CHARACTERISTICS : Women postmenopausal defined absence period past 12 month bilateral oophorectomy Women least one ovary without uterus deem postmenopausal either age 55 combination estrogen within postmenopausal range ( per local lab ) FSH 40 mIU/mL No woman childbearing potential premenopausal Creatinine clearance &gt; 30 mL/min Ability complete questionnaire ( ) assistance ECOG performance status 0 1 No history allergic adverse reaction magnesium No diabetes No patient condition implicate decreased absorption magnesium ( e.g. , Crohn disease , ETOH abuse ) No patient diarrhea magnesium might make bad ( per provider discretion ) PRIOR CONCURRENT THERAPY : None follow current ( ≤ 28 day prior registration ) plan therapy ( tamoxifen , raloxifene , aromatase inhibitor allow , patient must constant dose ≥ 28 day must expect stop medication study period ) : Antineoplastic chemotherapy ( trastuzumab lapatinib allow ) Androgens Estrogens ( delivery route ) Progestational agents No prior use magnesium hot flash No current plan use gabapentin ( reason ) antidepressant ( reason ) agent treat hot flash ( except stable dose vitamin E allow long start &gt; 30 day prior study registration continue study period ; soy allow , plan continue dose study period ) No current use magnesium indication ( except one standard multiple vitamin dose allow per day ) Not take diuretic , corticosteroid , bile acid sequestrants , prescription overthecounter medication may affect magnesium level No current ( ≤ 7 day prior registration ) plan use nondrug therapy manage hot flash , acupuncture yoga ( use therapy reason allow )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hot flash</keyword>
	<keyword>cancer survivor</keyword>
	<keyword>breast cancer</keyword>
</DOC>